<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Community:</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/22168</link>
    <description />
    <pubDate>Fri, 10 Apr 2026 10:03:23 GMT</pubDate>
    <dc:date>2026-04-10T10:03:23Z</dc:date>
    <item>
      <title>Culegerea de lucrări a Conferinței Internaționale "Imunopedia", ediția II, 9-10.09.2022</title>
      <link>http://repository.usmf.md:80/handle/20.500.12710/22609</link>
      <description>Title: Culegerea de lucrări a Conferinței Internaționale "Imunopedia", ediția II, 9-10.09.2022</description>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repository.usmf.md:80/handle/20.500.12710/22609</guid>
      <dc:date>2022-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>When do we have to think about primary immunodeficiency?</title>
      <link>http://repository.usmf.md:80/handle/20.500.12710/22581</link>
      <description>Title: When do we have to think about primary immunodeficiency?
Authors: Serban, Margit; Ursu, Emilia; Arghirescu, Smaranda
Abstract: Summary.&#xD;
Primary immunedeficiencies (PIDs) are rare disorders, with discordant statistics&#xD;
regarding their reported prevalence (dependent on population, country, PID center):&#xD;
1.51/100,000 (Germany), 4.97/100,000 (France), 12.4/ 100,000(Australia), 10/100,000&#xD;
(worldwide), 80-100/ 100, 000 inhabitants (EDQM). It is estimated that 1% of the&#xD;
global population has PID and &gt; 6 million persons suffer from PID worldwide, 70-90%&#xD;
of them remaining undiagnosed (I. Meyts, 2021; JM Boyle, 2007).; Rezumat.&#xD;
Imunodeficiențele primare (IDP) sunt tulburări rare, cu statistici discordante în ceea&#xD;
ce privește prevalența raportată (în funcție de populație, țară, centru PID): 1,51/100.000&#xD;
(Germania), 4,97/100.000 (Franța), 12,4/ 100.000 (Australia), 10/100.000 (în toată&#xD;
lumea), 80-100/ 100.000 locuitori (EDQM). Se estimează că 1% din populația globală&#xD;
are BIP și &gt; 6 milioane de persoane suferă de BIP la nivel mondial, 70-90% dintre ele&#xD;
rămânând nediagnosticate.</description>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repository.usmf.md:80/handle/20.500.12710/22581</guid>
      <dc:date>2022-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Wiskott-Aldrich syndrome at children - diagnostic particularities</title>
      <link>http://repository.usmf.md:80/handle/20.500.12710/22580</link>
      <description>Title: Wiskott-Aldrich syndrome at children - diagnostic particularities
Authors: Dorif, Alexandr; Secu, Doina; Sacara, Victoria
Abstract: Summary.&#xD;
Wiskott-Aldrich syndrome is a form of primary immune deficiency combined&#xD;
with thrombocytopenia and for a long time it was thought it is a single one with such&#xD;
symptoms, but now phenocopies are known. Another problem with this syndrome is a&#xD;
common problem of all primary immune deficiencies — majority of medical workers&#xD;
know very little about this group of diseases what leads to a very long times from the&#xD;
debute of disease to the specific diagnosis. Because of that, we shortly describe criteria&#xD;
for Wiskott-Aldrich and rekated disorders diagnostic and how we are performing&#xD;
molecular genetic diagnostic of it.; Rezumat.&#xD;
Sindromul Wiskott-Aldrich este o formă de imunodeficiență primară combinată&#xD;
cu trombocitopenie și multă vreme s-a crezut că este una singură cu astfel de simptome,&#xD;
dar acum se cunosc fenocopii. O altă problemă cu acest sindrom, comună tuturor&#xD;
deficiențelor imune primare - majoritatea lucrătorilor medicali știu foarte puțin despre&#xD;
acest grup de boli, ceea ce duce la un timp foarte lung de la debutul bolii până la&#xD;
diagnosticul specific. Din acest motiv, descriem pe scurt criteriile de diagnosticare a tulburărilor Wiskott-Aldrich și rekated și modul în care efectuăm diagnosticul genetic&#xD;
molecular al acesteia.</description>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repository.usmf.md:80/handle/20.500.12710/22580</guid>
      <dc:date>2022-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Infecția SARS-CoV-2 la copii cu imunodeficiențe primare</title>
      <link>http://repository.usmf.md:80/handle/20.500.12710/22541</link>
      <description>Title: Infecția SARS-CoV-2 la copii cu imunodeficiențe primare
Authors: Selvestru, Rodica; Sciuca, Svetlana; Tomacinschii, Cristina</description>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repository.usmf.md:80/handle/20.500.12710/22541</guid>
      <dc:date>2022-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

